Solid, modified-release pharmaceutical dosage forms which can be administered orally
    9.
    发明申请
    Solid, modified-release pharmaceutical dosage forms which can be administered orally 审中-公开
    可以口服给药的固体,改良释放药物剂型

    公开(公告)号:US20070026065A1

    公开(公告)日:2007-02-01

    申请号:US11317720

    申请日:2005-12-23

    IPC分类号: A61K31/5377 A61K9/22

    摘要: The present invention relates to solid, modified-release pharmaceutical dosage forms which can be administered orally and comprise 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide, and process for their production, their use as medicaments, their use for the prophylaxis, secondary prophylaxis and/or treatment of disorders, and their use for producing a medicament for the prophylaxis, secondary prophylaxis and/or treatment of disorders.

    摘要翻译: 本发明涉及可以口服给药并包含5-氯-N - ({(5S)-2-氧代-3- [4-(3-氧代-4-吗啉基) 苯基] -1,3-恶唑烷-5-基}甲基)-2-噻吩甲酰胺及其制备方法,它们作为药物的用途,其用于预防,二次预防和/或治疗疾病的用途及其用于 产生用于预防,二次预防和/或治疗疾病的药物。